THE CATALYTIC IMPACT FOUNDATION (CIF)

What THE CATALYTIC IMPACT FOUNDATION (CIF) does

The Catalytic Impact Foundation (CIF) is a private nonprofit foundation founded in 2017 and domiciled in Massachusetts, with a mailing address in Hingham, MA and meetings-by-appointment offices in Greater New York City, Greater Boston, and Seattle. CIF deploys philanthropic capital into early-stage healthcare and life science companies that address unmet medical needs, with a stated mission to bridge the "Valley of Death" funding gap between research grants and for-profit venture investment. The foundation operates a regenerative philanthropy model under which returns from portfolio investments are reinvested into future healthcare innovations, and it focuses its investments across six verticals: Children's Health, Brain and Mental Health, Women's Health, Rare Diseases, Health Equity, and Aging. CIF actively prioritizes women-led companies (51% of its active portfolio) via its Women Leaders in Health Innovation Initiative.

CIF's product surface consists of three programmatic channels: (1) direct equity investments and catalytic grants into early-stage companies, sourced through its advisor network of 25+ foundation advisors; (2) annual innovation prize competitions — the Children's Health Challenge and the Women's Health Innovation Prize — with standardized $100k winner / $50k runner-up awards and follow-on investment opportunities; and (3) a fiscal sponsorship program that provides financial oversight and nonprofit compliance for mission-aligned projects that lack their own 501(c)(3) status. Its portfolio spans 50+ companies including AOA Dx, Cleerly, Lyndra Therapeutics, Sonavi Labs, Alio, Deck Therapeutics, Pocket Naloxone, LunaJoy Health, DeepEcho, Feminai, Limax Biosciences, Flourish Care, Regatta Bio, Siloam Vision, and Tympanogen, with Applied Therapeutics' 2019 NASDAQ IPO (APLT) standing as the most prominent exit.

CIF has no traditional revenue model — it is funded by donor contributions and reinvested portfolio returns, and its revenue is not publicly disclosed. Deal flow is generated through the prize competition pipeline (e.g., 220 applicants for the 2026 Children's Health Challenge), advisor referrals, and co-hosted convenings such as the Power of X Women's Health Innovation Summit co-hosted with Cure and Women's Health Horizons. Customer segments are early-stage healthcare/life science companies seeking catalytic validation, women-led healthcare companies, and the broader donor base supporting the foundation's verticals; CIF's strategic and operating geographies span the U.S. Northeast, Southeast, and Pacific Northwest.

Name

THE CATALYTIC IMPACT FOUNDATION (CIF)

Legal name

Catalytic Impact Foundation

Website

http://www.cifimpact.org

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

The Catalytic Impact Foundation (CIF) is a nonprofit philanthropic foundation that deploys catalytic capital and runs innovation prize competitions for early-stage healthcare and life science companies across six underfunded verticals, including women's health, children's health, brain health, rare diseases, health equity, and aging.

Ownership category

akta.pro rank

Product category

Venture Philanthropy / Impact Investing

NAICS

Grantmaking and Giving Services (81321), Voluntary Health Organizations (813212), Religious, Grantmaking, Civic, Professional, and Similar Organizations (813)

SIC

Investment Advice (6282)

akta.pro primary industry

Public Charities & Grantmaking Intermediaries (BPAGAKAE)

akta.pro secondary industries

Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure) (FSAAALAG), Corporate Foundations & CSR Grantmaking (BPAGAKAC)

Keywords

• Venture philanthropy funding
• Impact investing foundation
• Early-stage healthcare investment
• Catalytic capital deployment
• Health innovation prizes

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Philanthropic Capital Deployment: CIF deploys philanthropic capital into early-stage healthcare and life science companies. The foundation operates a regenerative philanthropy model where investment returns are reinvested into future innovations, creating a sustainable cycle of impact funding rather than a traditional revenue-generating business.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

CIF is a nonprofit foundation that deploys philanthropic capital into early-stage healthcare and life science companies addressing unmet medical needs. The foundation operates a regenerative philanthropy model that uses grants and equity investments to bridge the "Valley of Death" funding gap between research grants and for-profit venture investment, reinvesting returns into future innovations across six health verticals. CIF also runs innovation prize competitions and a fiscal sponsorship program as additional channels for deploying catalytic capital.

Differentiator

Problem solved

Functional benefit

Brands

• Women's Health Initiative: CIF initiative focused on accelerating innovations addressing conditions that affect women exclusively, differently, or disproportionately.
• Children's Health Initiative
• Women Leaders in Health Innovation Initiative
• Women's Health Innovation Prize
• Children's Health Innovation Prize

Products and services

• Direct Investment (Equity and Grant Funding) Catalytic capital deployed as equity investments and grants directly into early-stage healthcare and life science companies addressing unmet medical needs. Available to enterprise/founder-level recipients globally.
• Innovation Prize Competitions Annual competitions including the Children's Health Innovation Prize and Women's Health Innovation Prize that award catalytic investment (typically $100k for winners, $50k for runners-up) plus follow-on investment opportunities to selected early-stage healthcare startups.
• Fiscal Sponsorship Program Program that provides tax-deductible charitable infrastructure and financial oversight to mission-aligned projects, organizations without 501(c)(3) status, and for-profit teams running mission-driven work. CIF provides nonprofit compliance while project teams lead the work.

Quantifiable outcome

• Over 12.93 million annual potential lives impacted across the children's health portfolio
• +5 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Partnerships

Two partnerships are on record, tiered core.

• CurecoreStrategic or Co-development Partner · 10 March 2026Cure co-hosts the Power of X Women's Health Innovation Summit with Women's Health Horizons and CIF support, bringing together leaders from science, medicine, investment, and policy to accelerate innovation in women's health. The summit features a pitch competition awarding up to $100,000 to early-stage startups.
• Women's Health HorizonscoreStrategic or Co-development Partner · 10 March 2026Women's Health Horizons co-hosts the Power of X Women's Health Innovation Summit alongside Cure, bringing together investors, founders, scientists, and healthcare leaders to spotlight women's health as a rapidly growing investable market. They also launched the WHH Media Platform and WHH Talent Division to expand the women's health network globally.

Scale indicators14 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Kapor Capital: Kapor Capital invests seed and early-stage capital in startups addressing systemic inequities, including health. CIF is comparable as an early-stage impact investor with a focus on underfunded populations.

Direct peers

• New Profit: New Profit is a nonprofit venture philanthropy firm that backs early-stage social entrepreneurs with capital and strategic support. CIF mirrors this approach in healthcare-specific verticals.
• Omidyar Network: Omidyar Network invests philanthropic capital into for-profit and nonprofit ventures across multiple impact verticals including health. CIF is comparable as a philanthropic impact investor applying venture-style diligence to grantmaking.
• Acumen: Acumen is a global impact investment fund that deploys patient capital into early-stage companies addressing poverty and health in underserved markets. CIF is comparable as a similarly structured impact investor focused on healthcare innovation.
• Echoing Green: Echoing Green provides seed funding and leadership development to social entrepreneurs. CIF's innovation prize competitions and follow-on investments are a comparable early-stage catalyst mechanism.
• Tara Health Foundation: Tara Health Foundation is a philanthropic foundation investing in women's health, wellbeing, and economic opportunity. CIF's Women's Health Initiative is directly comparable in mission and approach.
• Mulago Foundation: Mulago Foundation invests philanthropic capital in high-impact, cost-effective solutions to global poverty and health challenges. CIF is comparable in deploying philanthropic capital into early-stage ventures with measurable impact outcomes.
• Draper Richards Kaplan Foundation: DRK selects early-stage social enterprises and provides multi-year unrestricted funding and operational support. CIF's catalytic capital and prize structure parallels DRK's philanthropic venture model.

Broad incumbents

• Robert Wood Johnson Foundation: RWJF is the largest US health-focused philanthropy, funding health initiatives across a broad portfolio. CIF is comparable as a healthcare grantmaking foundation but at a much smaller scale and with venture-style investing.
• Helmsley Charitable Trust: The Helmsley Charitable Trust is a major global health philanthropy with multi-billion-dollar assets, including significant healthcare investment programs. CIF is comparable in healthcare grantmaking focus but at a smaller scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments65 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about THE CATALYTIC IMPACT FOUNDATION (CIF)